What is the global market size of Drug Discovery Outsourcing Market?

Global Drug Discovery Outsourcing Market size was valued at USD 3.26 billion in 2021 and is poised to grow from USD 3.5 billion in 2022 to USD 6.2 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Drug Discovery Outsourcing Market Size, Share, Growth Analysis, By Workflow(Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development), By Therapeutics Area(Respiratory system, Pain and Anesthesia, Oncology, Ophthalmology), By Service Type(Chemistry Services, Biology Services), By End User(Pharmaceutical & Biotechnology companies, Academic Institutes, and Others), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35C2011 | Region: Global | Published Date: October, 2024
Pages: 242 | Tables: 128 | Figures: 78

Drug Discovery Outsourcing Market Regional Insights

North America held the largest global drug discovery outsourcing market in 2021.

The United States dominates North America market. As per the CDC, I.e., the Centers for Disease Control and Prevention, around 1.7 million new cancer cases were reported in 2019 in the US, and about half a million people died of cancer. For every 100,000 individuals in the US, there are 439 new cancer cases and 146 cancer deaths. Furthermore, the large presence of contract research organizations will positively contribute to the growth of the cancer immunotherapy drug discovery outsourcing market.

Europe is also expected to emerge in the global competition due to high capital spending on healthcare infrastructure and streamlining of approval processes. This has led to the safe and quick approval of clinical drugs and treatments in the region, hence contributing to the increasing demand for cancer immunotherapy drugs and treatment options.

Asia Pacific will witness increasing demand for drug discovery outsourcing due to emerging economies such as China and India. The government bodies in these countries have positive reimbursement policies that also provide an impetus to the market in this region.

Drug Discovery Outsourcing Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Drug Discovery Outsourcing Market size was valued at around USD 3.4 billion in 2022 and is expected to rise from USD 3.6 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).

Global Drug Discovery Outsourcing Market is highly fragmented with the presence of several small and large market players operating all over the world. Major companies of the market are implementing on several business strategies such as new product launches, acquisition & mergers, collaboration, and partnerships for the expansion of their geographical presence and their product portfolio. 'Charles River Laboratories International, Inc. ', 'WuXi AppTec Co., Ltd. ', 'Laboratory Corporation of America Holdings (LabCorp) ', 'Evotec SE ', 'Covance Inc. ', 'Thermo Fisher Scientific Inc. ', 'Eurofins Scientific ', 'Pharmaron Beijing Co., Ltd. ', 'Syngene International Ltd. ', 'Genscript Biotech Corporation ', 'ChemPartner ', 'Jubilant Biosys Ltd. ', 'ICON plc ', 'QuintilesIMS (IQVIA) ', 'Cambrex Corporation ', 'Viva Biotech ', 'Domainex Ltd. ', 'Curia Global, Inc. (formerly Albany Molecular Research, Inc.) ', 'Tecan Group Ltd. ', 'Shanghai Medicilon Inc.'

The rising R&D expenditure of pharmaceutical and biopharmaceutical companies is prompting them to opt for fully integrated or functional outsourcing services, from the early development stage to the late-stage development phase, for drug discovery and development. As there is enormous pressure on pharma companies to contain fixed costs, outsourcing has evolved as a strategic alternative to overcome the lack of in-house resources required for new product development. Big pharma companies are transitioning to a leaner business model that relies heavily on outsourcing. Most pharmaceutical and biopharmaceutical companies outsource their testing functions during R&D to improve profitability, meet the timelines involved in drug development, and save costs. This is evident from the recent agreements by major pharmaceutical companies with CROs providing drug discovery and development services. Thus, increasing pharmaceutical R&D expenditure supports the growth of the drug discovery services market.

Increasing number of small and medium-sized companies are outsourcing drug discovery services, thus the value chain of drug discovery outsourcing market will have new growth opportunities in coming years.

North America held the largest global drug discovery outsourcing market in 2021.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Drug Discovery Outsourcing Market Regional Insights

Drug Discovery Outsourcing Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Drug Discovery Outsourcing Market?

Who are the key vendors in the Drug Discovery Outsourcing Market?

What is the key driver of Drug Discovery Outsourcing Market?

What is the key market trend for Drug Discovery Outsourcing Market?

Which region accounted for the largest share in Drug Discovery Outsourcing Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300